Abstract:Epithelial Ovarian cancer (EOC) is the deadliest gynecologic malignancy and represents the fifth leading cause of all cancer-related deaths in women. The majority of patients are diagnosed at an advanced stage of the disease that has spread beyond the ovaries to the peritoneum or to distant organs (stage FIGO III-IV) with a 5-year overall survival of about 29%. Consequently, it is necessary to understand the pathogenesis of this disease. Among the factors that contribute to cancer development, lipids and ion channels have been described to be associated to cancerous diseases particularly in breast, colorectal and prostate cancers. Here, we reviewed the literature data to determine how lipids or lipid metabolites may influence EOC risk or progression. We also highlighted the role and the expression of the calcium (Ca2+) and calcium-activated potassium (KCa) channels in EOC and how lipids might regulate them. Although lipids and some subclasses of nutritional lipids may be associated to EOC risk, lipid metabolism of LPA (lysophosphatidic acid) and AA (arachidonic acid) emerges as an important signaling network in EOC. Clinical data showed that they are found at high concentrations in EOC patients and in vitro and in vivo studies referred to them as triggers of the Ca2+entry in the cancer cells inducing their proliferation, migration or drug resistance. The cross-talk between lipid mediators and Ca2+ and/or KCa channels needs to be elucidated in EOC in order to facilitate the understanding of its outcomes and potentially suggest novel therapeutic strategies including treatment and prevention.

Association of Lipid Metabolism with Ovarian Cancer

Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer and metastasis

Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer

The Role of Aberrant Metabolism in Cancer: Insights into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer

Ovarian Cancer-Why Lipids Matter

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer

Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications

Targeting lipid metabolism in the treatment of ovarian cancer

Association between abnormal lipid metabolism and tumor

Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways

Obesity Contributes to Ovarian Cancer Metastatic Success Through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages

High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism

Research of the Correlation between Lipid Metabolic and Endometrial Cancer

The Regulatory Role of Lipid Metabolism in Endometrial Cancer

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets

Lipid metabolism and cancer

Lipid metabolism and Calcium signaling in epithelial ovarian cancer

Etiological relationship between lipid metabolism and endometrial carcinoma

Lipid metabolism in tumor microenvironment: novel therapeutic targets

Unravelling the role of obesity and lipids during tumor progression